PGO0 logo

Prostatype Genomics DB:PGO0 Stock Report

Last Price

€0.69

Market Cap

€922.9k

7D

-13.4%

1Y

-90.1%

Updated

05 Nov, 2024

Data

Company Financials

Prostatype Genomics AB (publ)

DB:PGO0 Stock Report

Market Cap: €922.9k

PGO0 Stock Overview

Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests.

PGO0 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Prostatype Genomics AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Prostatype Genomics
Historical stock prices
Current Share PriceSEK 0.69
52 Week HighSEK 12.80
52 Week LowSEK 0.68
Beta0.69
11 Month Change-13.40%
3 Month Change-65.36%
1 Year Change-90.10%
33 Year Change-99.93%
5 Year Changen/a
Change since IPO-99.94%

Recent News & Updates

Recent updates

Shareholder Returns

PGO0DE BiotechsDE Market
7D-13.4%0.7%-1.3%
1Y-90.1%-15.4%13.9%

Return vs Industry: PGO0 underperformed the German Biotechs industry which returned -14.4% over the past year.

Return vs Market: PGO0 underperformed the German Market which returned 13.3% over the past year.

Price Volatility

Is PGO0's price volatile compared to industry and market?
PGO0 volatility
PGO0 Average Weekly Movement26.4%
Biotechs Industry Average Movement5.8%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.5%
10% least volatile stocks in DE Market2.3%

Stable Share Price: PGO0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: PGO0's weekly volatility (26%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20076Fredrik Rickmanwww.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company’s test is based on database containing prostate cancer patients, as well as provides decision support for patients and doctors when making a treatment decision.

Prostatype Genomics AB (publ) Fundamentals Summary

How do Prostatype Genomics's earnings and revenue compare to its market cap?
PGO0 fundamental statistics
Market cap€922.93k
Earnings (TTM)-€3.46m
Revenue (TTM)€351.66k

2.6x

P/S Ratio

-0.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PGO0 income statement (TTM)
RevenueSEK 4.12m
Cost of RevenueSEK 20.11m
Gross Profit-SEK 16.00m
Other ExpensesSEK 24.54m
Earnings-SEK 40.54m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 13, 2025

Earnings per share (EPS)-40.92
Gross Margin-388.80%
Net Profit Margin-985.22%
Debt/Equity Ratio0%

How did PGO0 perform over the long term?

See historical performance and comparison